Skip to content
Review

From historical breakthroughs to a modern framework for antibiotic discovery

Aug 2026 · Biologia · Vol 81 · 0 citations · 115 references

TL;DR

The review highlights the need for greater exploration of natural resources and redesigning of antibiotic development strategies to break free the stagnation that has been dominating the field of AMR for decades.

View source

Similar papers

Review Aug 2026

New Natural Product Antibiotics: Strategies and Tools That Offer New Approaches to Overcome Traditional Roadblocks.

Advances in genomics, bioinformatics, and analytical chemistry have, in recent years, combined to show that there is still significant chemical diversity to be explored in microbes, providing an opportunity to revisit natural products for antibiotic discovery.

Maya George, Marie I. Balea, Gerard D. Wright · 0 citations
#generative ai Review Open access Sep 2026

From Days to Hours: Artificial Intelligence in Antimicrobial Resistance Diagnostics and Drug Discovery, and Why No Tool Has Yet Reached the Clinic

Artificial intelligence has moved convincingly beyond proof-of-concept in AMR diagnostics and discovery, but its path to the clinic now depends less on further algorithmic refinement than on prospective validation, equitable data representation, and interpretability standards that clinicians can reasonably trust.

Unknown authors · 0 citations
Open access Sep 2026

Comparative Analysis of Conventional Antibiotics and Next-Generation Alternatives in Combating Antibiotic Resistance: Why Static Drugs Cannot Outpace an Adaptive Genome

Antibiotic resistance poses a threat to decades of clinical improvement and modern medicine, as antibiotics serve as the backbone of modern medicine, driven by a fundamental evolutionary mismatch: static antibiotics cannot outpace the rapidly adapting bacterial genome. Also, the development pipeline is stalled; antibio...

George Moromoke Ugochukwu · 0 citations
Review Open access Aug 2026

AI-enabled discovery of small molecule β-lactamase inhibitors to overcome enzyme diversity and resistance evolution.

Artificial intelligence (AI) is reshaping modern drug discovery by enabling data-driven exploration of chemical space, predictive modeling of molecular interactions, and multi-objective optimization of therapeutic candidates. These capabilities are particularly important in addressing antimicrobial resistance, where co...

Perwez Bakht, Rinki Gupta, Tarun Gangar et al. · 0 citations
Review Open access Aug 2026

Emerging Strategies in Antimicrobial Drug Discovery: A Review of Target-Based and Phenotypic Screening Approaches

Antimicrobial resistance has intensified the need for new chemical matter and new mechanisms of action, yet antibacterial discovery remains unusually vulnerable to attrition between a convincing molecular hypothesis and clinically relevant whole-cell activity. This critical narrative review evaluates target-based and p...

I. Aliyu, Zephaniah Isaiah, Samson Tesfaye Gebre et al. · 0 citations
Review Open access Aug 2026

Antimicrobial Resistance and the Repurposing of Primaquine: A Review of Design, Screening and Antibacterial Evaluation

Antimicrobial resistance is now among the most pressing threats to global healthcare. Infections that were once routinely treatable increasingly survive first-line therapy, while the discovery pipeline for genuinely novel antibacterial agents has slowed to a near halt. MRSA is linked to close to 50,000 deaths annually...

K. K · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.